[Federal Register Volume 69, Number 209 (Friday, October 29, 2004)]
[Notices]
[Page 63161]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-24168]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting; Interagency Autism Coordinating Committee

    The National Institutes of Health (NIH) hereby announces a meeting 
of the Interagency Autism Coordinating Committee (IACC) to be held on 
November 19, 2004, on the NIH campus in Bethesda, Maryland.
    The Children's Health Act of 2000 (Pub. L. 106-310), Title I, 
Section 104, mandated the establishment of an IACC to coordinate autism 
research and other efforts within the Department of Health and Human 
Services. In April 2001, Secretary Tommy Thompson delegated the 
authority to establish the IACC to the NIH. The National Institute of 
Mental Health (NIMH) at the NIH has been designated the lead for this 
activity.
    The IACC meeting will be open to the public, with attendance 
limited to space available. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the contact person listed 
below in advance of the meeting.

    Name of Committee: Interagency Autism Coordinating Committee.
    Date: November 19, 2004.
    Time: 9 a.m.-4:30 p.m.
    Agenda: Discussion of autism activities across Federal agencies.
    Place: National Institutes of Health, 31 Center Drive, Building 
31, Conference Room 10 (6th floor), Bethesda, Maryland 20892.
    Contact Person: Ann Wagner, Ph.D., Division of Services and 
Intervention Research, National Institute of Mental Health, NIH, 
6001 Executive Boulevard, Room 7142, MSC 9633, Bethesda, Maryland 
20892. E-mail: [email protected]. Phone: 301-443-4283.

    Any member of the public interested in presenting oral comments to 
the Committee may notify the contact person listed on this notice at 
least 5 days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a brief 
description of the organization represented, and a short description of 
the oral presentation. Presentations may be limited to 5 minutes; both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding his/her statement to the contact person listed 
on this notice. The statement should include the name, address, 
telephone number, and, when applicable, the business or professional 
affiliation of the interested person.
    Information about the meeting and online registration forms are 
also available on-line on the NIMH home page at http://www.nimh.nih.gov/autismiacc/index.cfm.

    Dated: October 20, 2004.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 04-24168 Filed 10-28-04; 8:45 am]
BILLING CODE 4140-01-P